The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AVIDITY BIOSCIENCES INC | COM | 05370A108 | 8,108,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 14,267,143 | 325,140 | SH | SOLE | 325,140 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 246,073,509 | 4,575,558 | SH | SOLE | 4,575,558 | 0 | 0 | |||
| ELEVATION ONCOLOGY INC | COM | 28623U101 | 4,809,888 | 1,916,290 | SH | SOLE | 1,916,290 | 0 | 0 | |||
| GERON CORP | COM | 374163103 | 106,184,731 | 23,915,480 | SH | SOLE | 23,915,480 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 237,076,310 | 3,541,095 | SH | SOLE | 3,541,095 | 0 | 0 | |||
| KEROS THERAPEUTICS INC | COM | 492327101 | 68,772,403 | 1,525,902 | SH | SOLE | 1,525,902 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 10,265,828 | 452,040 | SH | SOLE | 452,040 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 163,916,116 | 2,080,946 | SH | SOLE | 2,080,946 | 0 | 0 | |||